Long-term effect of transurethral partial cystectomy with a 2-micrometer continuous-wave laser for non-muscle-invasive bladder cancer

Purpose We have reported the efficacy and safety of 2-micrometer continuous-wave laser cystectomy of non-muscle invasive bladder tumor (NMIBC) (J Urol. 2009;182:66–9). In this study, we evaluated the long-term outcomes of patients with NMIBC who underwent transurethral partial cystectomy with a 2-micrometer continuous-wave laser, and explored the risk factors for tumor recurrence. Methods This was a retrospective study of patients with NMIBC planned to undergo transurethral partial cystectomy with a 2-micrometer continuous-wave laser at the Fourth Medical Center of the PLA General Hospital between January 2012 and December 2014. The primary outcome was bladder cancer recurrence. Results A total of 75 patients were enrolled. Sixty-two (82.7%) were male. The patients were 59.8 ± 12.9 years of age. The mean operation time was 38.7 ± 20.4 min. No Clavien grade >2 complications occurred. The duration of catheter indwelling was 3.6 ± 1.8 days. The hospital stay was 6.0 ± 2.3 days. The median follow-up was 80 months. A total of 17 patients had a recurrence during follow-up, and the recurrence-free survival (RFS) rate was 77.3%. In the multivariable analysis, the tumor risk group were independently associated with the recurrence of NMIBC (p = 0.026). Conclusions After TURBT with a 2-micrometer continuous-wave laser, RFS was 77.3% at the median follow-up of 80 months. All complications were mild. Only tumor risk group was independently associated with the recurrence of NMIBC.

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  A. Lenis,et al.  Bladder Cancer: A Review. , 2020, JAMA.

[3]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[4]  J. Witjes,et al.  European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. , 2020, European urology.

[5]  Yair Lotan,et al.  Bladder cancer , 2020, Nature Reviews Disease Primers.

[6]  S. Boorjian,et al.  Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  Shahrokh F. Shariat,et al.  European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. , 2019, European urology.

[8]  Mingyue Tan,et al.  A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer , 2018, Lasers in Medical Science.

[9]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[10]  K. DeGeorge,et al.  Bladder Cancer: Diagnosis and Treatment. , 2017, American family physician.

[11]  A. Verma,et al.  Holmium laser transurethral resection of bladder tumor: Our experience , 2016, Urology annals.

[12]  N. Malats,et al.  The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin , 2016, BJU international.

[13]  Wei Wang,et al.  Thulium laser treatment for bladder cancer , 2016, Asian journal of urology.

[14]  R. Migliari,et al.  Thulium Laser Endoscopic En Bloc Enucleation of Nonmuscle-Invasive Bladder Cancer. , 2015, Journal of endourology.

[15]  A. Yıldırım,et al.  Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high‐risk non‐muscle‐invasive bladder cancer treated with maintenance intravesical Bacillus Calmette‐Guérin , 2015, BJU international.

[16]  C. Feng,et al.  Two Micrometer Continuous-Wave Thulium Laser Treating Primary Non-Muscle-Invasive Bladder Cancer: Is It Feasible? A Randomized Prospective Study. , 2015, Photomedicine and laser surgery.

[17]  Junhua Zheng,et al.  Comparative Study of 2um Laser versus Ho lmium Laser for the Resectionof Non-Muscle Invasive Bladder Cancer , 2015 .

[18]  P. Han,et al.  Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis , 2014, World Journal of Surgical Oncology.

[19]  Yuanzhong Yang,et al.  En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial , 2014, World Journal of Urology.

[20]  S. Xia,et al.  Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer , 2013, The Journal of international medical research.

[21]  X. Cui,et al.  Holmium laser versus conventional transurethral resection of the bladder tumor , 2013, Chinese medical journal.

[22]  D. Silverman,et al.  Association between smoking and risk of bladder cancer among men and women. , 2011, JAMA.

[23]  B. Han,et al.  2‐micrometer continuous wave laser treatment for multiple non‐muscle‐invasive bladder cancer with intravesical instillation of epirubicin , 2011, Lasers in surgery and medicine.

[24]  S. Xia,et al.  Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience , 2010, World Journal of Urology.

[25]  B. Hong,et al.  Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. , 2009, The Journal of urology.

[26]  M. Soloway,et al.  Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. , 2005, The Journal of urology.

[27]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[28]  P A Dekker-de Kiefte,et al.  Diagnosis and Treatment , 2020, Diabetes.

[29]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[30]  I. T. Kobyliatskiĭ [OUR EXPERIENCE]. , 1963, Sovetskoe zdravookhranenie.